News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news.
Jyoti Patel, MD, will join Northwestern Medicine as Medical Director of Thoracic Oncology and Assistant Director for Clinical Research at the Lurie Cancer Center, effective November 1, 2019. She will also serve as Associate Vice Chair for Clinical Research in the Department of Medicine.
High levels of folate, a B vitamin, can force glial nerve cells to transform back into undifferentiated stem cells, according to a new study published in the journal Stem Cells.
A multi-institutional study led by Edward M. Schaeffer, MD, PhD, is the largest genomic analysis of prostate cancer to date, encompassing nearly 20,000 patients with localized prostate cancer.
A revolutionary new approach that analyzes a tiny sample of blood, can detect life-threatening vascular complications in diabetic patients earlier and more accurately than traditional tests.
- Vadim Backman Named Associate Director for Research Technology and Infrastructure at Lurie Cancer Center10.01.2019
Vadim Backman, PhD, has been named Associate Director for Research Technology and Infrastructure at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, effective October 1.
The first prostate cancer treatment based on the genetic makeup of the cancer resulted in significant improvements, according to a large international trial led by Northwestern Medicine investigators.
Genetic-based treatment nearly doubles time without disease progression in metastatic prostate cancer.
Hear Rimas Lukas, MD, discuss promising new clinical trials and other research underway to improve glioblastoma treatment.
In recognition of its commitment to cutting-edge research and cancer care, Mayor Lori Lightfoot proclaimed September 20, 2019 as Hippocratic Cancer Research Foundation Day in Chicago.
Maha Hussain, MD, deputy director of the Lurie Cancer Center and medical director of our Genitourinary Oncology Program, is an internationally renowned clinical investigator and expert in genitourinary oncology. She was recognized by OncLive as a Giant of Cancer Care in Genitourinary Cancers for her landmark achievements within the global field of oncology.
Students, faculty and staff gathered to celebrate the Driskill Graduate Program in Life Sciences, welcoming new students and recognizing distinguished upperclassmen and graduates.
Milan Mrksich, the Henry Wade Rogers Professor at Northwestern, has been named Northwestern University’s Interim Vice President for Research, Provost Jonathan Holloway announced today (Sept. 12). Mrksich also will serve as a member of President Morton Schapiro’s senior staff.
Each year more than 330,000 American women look in the mirror and see breast cancer staring back at them—not necessarily in the form of the disease itself, but in the ravages of treatment.
Jessica Altman, MD, director of Lurie Cancer Center’s Acute Myeloid Leukemia Program, was featured in the September issue ofthe American Society of Hematology’s new magazine, ASH Clinical News.
The safety of a new therapy for an aggressive brain tumor was demonstrated in a recent clinical trial, and the drug also cleared other important hurdles.
- International Collaboration to Improve Cancer Care in Sub-Saharan Africa Announces Management of Most Adult Cancers Covered by NCCN Harmonized Guidelines08.28.2019
National Comprehensive Cancer Network, African Cancer Coalition, and American Cancer Society launch new phase focused on updating adult cancer guidelines and adding new guidelines for treating children with cancer.
Northwestern Medicine scientists have identified a protein that helps reprogram HER2-positive breast cancer cells to survive in the brain, according to a recent study.
Some physicians do not counsel cancer survivors on adopting a healthy lifestyle, study reports
Lurie Cancer Center is pleased to announce that Adam Lin, MD, PhD, has been selected by the American Society of Hematology (ASH), as one of 16 outstanding fellows in the U.S. to receive the 2019 ASH Research Training Award for Fellows (RTAF), a year-long program that aims to encourage careers in academic hematology by providing protected research time during training.
A new blood test can identify early-stage liver cancer, allowing clinicians to start treatment early, according to a new study.
See more news in the article archive.